Accelerate Diagnostics Posts Q3 Revenue Gain | GenomeWeb

NEW YORK (GenomeWeb News) – Accelerate Diagnostics today reported that revenues for its third quarter jumped 151 percent year over year.

Revenues for the three months ended Sept. 30 rose to $12,797 from $5,115 in the year-ago period "due to fluctuations in partner sales volumes on which royalties were due the company," Accelerate said in its quarterly earnings document filed with the US Securities and Exchange Commission.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.